Both in Pharmaceuticals
Ligand Pharmaceuticals vs Axsome Therapeutics
Over the past year LGND returned +64.0% and AXSM returned +4.7%; their daily moves had a correlation of 0.25.
LGND +64.0% AXSM +4.7%Growth of $1, one year, split-adjusted
| Metric | LGND | AXSM |
|---|---|---|
| Price | $313.61 | $142.17 |
| Market cap | $6.27B | $7.45B |
| Today | +2.14% | +4.53% |
| 1 month | +2.2% | −19.7% |
| 6 months | +35.0% | −36.3% |
| Year to date | +65.9% | −22.2% |
| 1 year | +63.9% | +5.3% |
| Revenue growth (YoY) | −31.8% | +51.9% |
| Gross margin | 83.7% | 93.1% |
| Net margin | −36.2% | −5.0% |
| P/E (TTM) | 121.9× | — |
| Price / sales | 24.7× | 8.6× |
| Net cash | -$653.3M | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 38.9% |
| Short % of float | 13.3% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).